Immunovia resolves on a rights issue of approximately SEK 20

NOT FOR PUBLICATION, RELEASE DISSEMINATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG...

Related Keywords

Australia , Japan , United States , Hong Kong , District Of Columbia , Stockholm , Sweden , United Kingdom , Singapore , Canada , Switzerland , Swedish , American , Immunovia Immray , Carl Borrebaeck , Immunovia Immray Pancan D , Immray Pancan D , Karin Almqvist Liwendahl , Ranny Davidoff , Philipp Mathieu , Centers For Medicare Medicaid Services , Swedish Companies Registration Office Sw , Company Board Of Directors , Us Pancreatic Cancer Action Network , Current Procedural Terminology Proprietary Laboratory Analyzes , Financial Services , American Medical Association , Immunovia Inc , Company On Immunovia , Clinical Lab Fee Schedule , Rights Issue , Extraordinary General Meeting , Vator Securities , Mats Ohlin , Medicaid Services , Lab Fee Schedule , Key Opinion Leaders , Nasdaq Stockholm , Swedish Companies Registration Office , Vator Securitie , Advokatfirman Vinge , Nasdaq First North , New Zealand , South Africa , United States Securities Act , Securities Act , Relevant State , Prospectus Regulation , Markets Act , Financial Promotion , Cancer Action , New Early Detection Blood Tests , Immunovia Ab ,